HPC — Hydration Pharmaceuticals Co Income Statement
0.000.00%
Last trade - 00:00
- AU$2.74m
- AU$8.48m
- $10.04m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.96 | 3.76 | 6.13 | 9.1 | 10 |
Cost of Revenue | |||||
Gross Profit | 1.38 | 1.34 | 2.79 | 4.7 | 5.39 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.4 | 4.5 | 14.4 | 19.7 | 18.1 |
Operating Profit | -3.43 | -0.744 | -8.29 | -10.6 | -8.1 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.43 | -0.744 | -8.95 | -10.6 | -8.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.43 | -0.744 | -8.95 | -10.6 | -8.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.43 | -0.744 | -8.95 | -10.6 | -8.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.43 | -0.744 | -8.95 | -10.6 | -8.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.021 | -0.021 | -0.06 | -0.063 | -0.042 |
Dividends per Share |